Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants
- PMID: 1519988
- PMCID: PMC1590416
- DOI: 10.1136/adc.67.7_spec_no.851
Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants
Abstract
Cerebral blood flow velocity was assessed during infusion of indomethacin over 30 minutes. Eleven preterm infants with symptomatic patent ductus arteriosus were studied on 12 occasions. Indomethacin infusion was associated with a significant reduction in time averaged mean velocity (TAMV), peak systolic velocity (PSV), and end diastolic velocity in both the anterior cerebral artery and middle cerebral artery. The fall in the TAMV and PSV was gradual with maximal change 30-40 minutes after the start of the infusion. It was concluded that administration of indomethacin by slow infusion produces haemodynamic alterations to the cerebral circulation comparable in magnitude with changes described with bolus administration. Indomethacin remains a useful and effective treatment for patent ductus arteriosus in preterm infants, but should continue to be used with caution.
Similar articles
-
Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect.Pediatrics. 1989 Nov;84(5):802-7. Pediatrics. 1989. PMID: 2677960
-
Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity.Pediatrics. 1995 Feb;95(2):244-8. Pediatrics. 1995. PMID: 7838642 Clinical Trial.
-
Effect of infusion rate of indomethacin on cerebrovascular responses in preterm neonates.Arch Dis Child. 1989 Jan;64(1 Spec No):8-12. doi: 10.1136/adc.64.1_spec_no.8. Arch Dis Child. 1989. PMID: 2923488 Free PMC article.
-
Therapeutic closure of the ductus arteriosus: benefits and limitations.J Matern Fetal Neonatal Med. 2009;22 Suppl 3:14-20. doi: 10.1080/14767050903198132. J Matern Fetal Neonatal Med. 2009. PMID: 19925358 Review.
-
Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.Clin Perinatol. 1995 Jun;22(2):457-79. Clin Perinatol. 1995. PMID: 7671547 Review.
Cited by
-
Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit.Clin Perinatol. 2012 Mar;39(1):111-36. doi: 10.1016/j.clp.2011.12.002. Epub 2012 Jan 13. Clin Perinatol. 2012. PMID: 22341541 Free PMC article. Review.
-
Patent ductus arteriousus in the premature neonate: current concepts in pharmacological management.Paediatr Drugs. 1999 Apr-Jun;1(2):81-92. doi: 10.2165/00128072-199901020-00002. Paediatr Drugs. 1999. PMID: 10937444 Review.
-
Multiple courses of indomethacin and neonatal outcomes in premature infants.Pediatr Cardiol. 2008 Sep;29(5):878-84. doi: 10.1007/s00246-007-9166-z. Epub 2007 Dec 18. Pediatr Cardiol. 2008. PMID: 18094917 Free PMC article.
-
Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?Semin Perinatol. 2012 Apr;36(2):123-9. doi: 10.1053/j.semperi.2011.09.022. Semin Perinatol. 2012. PMID: 22414883 Free PMC article. Review.
-
Acetaminophen versus indomethacin for patent ductus arteriosus management in premature infants: systematic review and meta-analysis of randomized controlled trials.Paediatr Child Health. 2023 Apr 4;28(5):291-298. doi: 10.1093/pch/pxac130. eCollection 2023 Aug. Paediatr Child Health. 2023. PMID: 37484043 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical